UAB Rx pharma Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
22,680,771 |
3,240,110 |
1,648,899 |
1,495,990 |
213,713 |
6.12 |
6.60 |
3,832,993 |
969,189 |
4,101 |
4,798,144 |
2023 |
---|
23,350,098 |
3,113,346 |
593,879 |
516,487 |
68,865 |
5.49 |
2.21 |
3,849,480 |
1,260,767 |
4,064 |
5,102,887 |
2024 |
---|
24,666,210 |
3,479,014 |
585,766 |
505,383 |
71,281 |
5.41 |
2.05 |
3,354,863 |
3,217,287 |
6,300 |
6,601,011 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
24,666,210 €6 % *
Sales per employee (€)
3,479,014 €12 % *
Profit before tax (€)
585,766 €-1 % *
Net Profit (€)
505,383 €-2 % *
Profit per employee (€)
71,281 €4 % *
Total profitability (%)
5.41 %-1.46 % *
Net profitability (%)
2.05 %-7.24 % *
Equity (€)
3,354,863 €-13 % *
Amounts Payable And Liabilities (€)
3,217,287 €155 % *
Non-current Assets (€)
6,300 €55 % *
CurrentAssets (€)
6,601,011 €29 % *